Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | An Open-label, Multicenter Phase 1 Study to Characterize the Safety, Tolerability, Preliminary Antileukemic Activity, Pharmacokinetics, and Maximum Tolerated Dose or Pharmacological Active Dose of BAY2402234 in Patients With Advanced Myeloid Malignancies |
---|---|
Disease/Condition | Myelodysplastic Syndrome (MDS),Leukemia,Cancer,Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Amit Verma, MD |
Contact Name | Apoorva Talanki |
Contact Email | atalanki@montefiore.org |
Protocol Number | 18-06-93-01 |
Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Acute Leukemia |
Adult, Pediatric, Both | Adult |